期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Anabolic androgenic steroid-induced liver injury:An update
1
作者 Ana Petrovic sonja vukadin +5 位作者 Renata Sikora Kristina Bojanic Robert Smolic Davor Plavec George Y Wu Martina Smolic 《World Journal of Gastroenterology》 SCIE CAS 2022年第26期3071-3080,共10页
Anabolic androgenic steroids(AASs)are a group of molecules including endogenous testosterone and synthetic derivatives that have both androgenic and anabolic effects.These properties make them therapeutically benefici... Anabolic androgenic steroids(AASs)are a group of molecules including endogenous testosterone and synthetic derivatives that have both androgenic and anabolic effects.These properties make them therapeutically beneficial in medical conditions such as hypogonadism.However,they are commonly bought illegally and misused for their anabolic,skeletal muscle building,and performanceenhancing effects.Supraphysiologic and long-term use of AASs affects all organs,leading to cardiovascular,neurological,endocrine,gastrointestinal,renal,and hematologic disorders.Hepatotoxicity is one of the major concerns regarding AASs treatment and abuse.Testosterone and its derivatives have been most often shown to induce a specific form of cholestasis,peliosis hepatis,and hepatic benign and malignant tumors.It is currently believed that mechanisms of pathogenesis of these disorders include disturbance of antioxidative factors,upregulation of bile acid synthesis,and induction of hepatocyte hyperplasia.Most toxicity cases are treated with supportive measures and liver function normalizes with discontinuation of AAS.However,some long-term consequences are irreversible.AAS-induced liver injury should be taken in consideration in patients with liver disorders,especially with the increasing unintentional ingestion of supplements containing AAS.In this paper,we review the most current knowledge about AAS-associated adverse effects on the liver,and their clinical presentations,prevalence,and pathophysiological mechanisms. 展开更多
关键词 ANDROGENS STEROIDS CHOLESTASIS FIBROSIS Liver Chemical and drug induced liver injury
下载PDF
Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update 被引量:1
2
作者 Kristina Bojanic Mirta Sudaric Bogojevic +7 位作者 sonja vukadin Renata Sikora Gordana Ivanac Nikola Raguz Lucic Martina Smolic Ashraf ATabll George YWu Robert Smolic 《Journal of Clinical and Translational Hepatology》 SCIE 2023年第5期1228-1238,共11页
Liver biopsy is historically the gold standard for liver fibrosis assessment of chronic hepatitis C patients.However,with the introduction and validation of noninvasive tests(NITs)to evaluate advanced fibrosis,and the... Liver biopsy is historically the gold standard for liver fibrosis assessment of chronic hepatitis C patients.However,with the introduction and validation of noninvasive tests(NITs)to evaluate advanced fibrosis,and the direct-acting antiviral agents for treatment of chronic hepatitis C virus(HCV),the role of NITs have become even more complex.There is now need for longitudinal monitoring and elucidation of cutoff values for prediction of liver-related complication after sustained virological response.The aim of this report is to provide a critical overview of the various NITs available for the assessment of liver fibrosis in HCV patients. 展开更多
关键词 Hepatitis C virus FIBROSIS Noninvasive serum fibrosis markers Transient elastography Shear wave elastography Magnetic resonance elastography STEATOHEPATITIS
原文传递
Drug-induced Fatty Liver Disease:Pathogenesis and Treatment
3
作者 Tea Omanovic Kolaric Vjera Nincevic +6 位作者 Lucija Kuna Kristina Duspara Kristina Bojanic sonja vukadin Nikola Raguz-Lucic George Y Wu Martina Smolic 《Journal of Clinical and Translational Hepatology》 SCIE 2021年第5期731-737,共7页
Metabolic dysfunction-associated fatty liver disease(commonly known as MAFLD)impacts global health in epidemic proportions,and the resulting morbidity,mortality and economic burden is enormous.While much attention has... Metabolic dysfunction-associated fatty liver disease(commonly known as MAFLD)impacts global health in epidemic proportions,and the resulting morbidity,mortality and economic burden is enormous.While much attention has been given to metabolic syndrome and obesity as offending factors,a growing incidence of polypharmacy,especially in the elderly,has greatly increased the risk of drug-induced liver injury(DILI)in general,and drug-induced fatty liver disease(DIFLD)in particular.This review focuses on the contribution of DIFLD to DILI in terms of epidemiology,pathophysiology,the most common drugs associated with DIFLD,and treatment strategies. 展开更多
关键词 Metabolic dysfunction-associated fatty liver disease Drug-induced liver injury Reactive oxygen species Free fatty acids PHARMACOGENETICS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部